Latest Market News

Page 22 of 1949
Imugene has dosed the first patient in a new cohort combining its azer-cel CAR T therapy with BTK inhibitors, targeting patients with B-cell malignancies who failed prior BTKi treatment. This move broadens the trial’s scope and tackles a significant unmet need in blood cancer therapy.
Ada Torres
Ada Torres
28 May 2026
Peet Limited has upgraded its FY26 net profit guidance by up to 17%, driven by accelerated construction and robust market demand in Western Australia and Queensland.
Eva Park
Eva Park
28 May 2026
Aspermont Limited (ASX:ASP) reported a 147% jump in net profit and 11% revenue growth for H1 FY26, driven by steady subscription growth and a ramp-up in non-subscription revenues. The company’s self-funded data and intelligence platform is on track, with Rio Tinto’s enterprise contract validating its strategic pivot.
Victor Sage
Victor Sage
28 May 2026
Develop Global’s Pioneer Dome lithium project hits high-grade infill drilling results surpassing resource expectations, setting the stage for a Final Investment Decision next month on an 850,000-tonne DSO operation.
Maxwell Dee
Maxwell Dee
28 May 2026
Beonic Ltd (ASX:BEO) has initiated a $3 million pro-rata renounceable entitlement offer at $0.08 per share, partially underwritten by Alpine Capital, to shore up working capital and repay shareholder loans. The offer carries potential dilution of 35.7% for non-participating shareholders and may increase the Thorney Group's voting power significantly.
Sophie Babbage
Sophie Babbage
28 May 2026
Tetratherix Limited secures $15 million via institutional placement plus a capped $2 million share purchase plan at a 14% discount, aiming to fast-track manufacturing expansion and commercial partnerships.
Ada Torres
Ada Torres
28 May 2026
Select Harvests delivered a 33% rise in underlying NPAT despite a wet harvest and higher costs, announcing a fully franked interim dividend and a 10% on-market share buy-back.
Ada Torres
Ada Torres
28 May 2026
Sunshine Metals has secured $7.7 million through an oversubscribed Share Purchase Plan, exceeding its $3 million target, to fund the Mt Moss processing facility acquisition and Liontown mine start-up.
Maxwell Dee
Maxwell Dee
28 May 2026
Australian Clinical Labs appoints Greg Horan as Group CEO effective August 2026, marking a leadership transition after a decade under Melinda McGrath. Horan’s healthcare and operational expertise positions ACL for its next growth phase.
Ada Torres
Ada Torres
28 May 2026
OncoSil Medical has secured a pivotal ethics committee approval in Italy, reclassifying its OSPRItaly registry and enabling a streamlined procurement process that could double the number of authorised hospitals using its OncoSil™ device by mid-2027.
Ada Torres
Ada Torres
28 May 2026
Acrux has amended its licensing agreement with Gedeon Richter to bring its Estradiol spray Lenzetto® to Australia, unlocking up to AUD 5.4 million in milestone payments and addressing a critical shortage in Menopause Hormone Therapy products.
Ada Torres
Ada Torres
28 May 2026
Jameson Resources has cleared a major environmental hurdle for its Crown Mountain steelmaking coal project, receiving the Section 27 Notice from British Columbia regulators and setting the stage for final application submission in October 2026.
Maxwell Dee
Maxwell Dee
28 May 2026